Communiqués DocMorris AG

Actions

ROSE

CH0042615283

Pharmacies

Marché Fermé - Swiss Exchange Autres places de cotation 17:31:48 14/07/2026			Varia. 5j.	Varia. 1 janv.
10,16 ^CHF	+0,99%		+10,74%	+70,76%

13/07	Bourse Zurich: le SMI choisit la confiance	AW
13/07	Les actions suisses entament la semaine dans le vert ; le titre DocMorris s'envole	MT

Communiqués

07:01	DocMorris reports strong revenue growth of 15% in the second quarter; Rx grows by 46% and Digital Services by 80%	EQ
25/06	DocMorris announces accelerated implementation of its “AI-First” strategy; positive cost savings of at least CHF 15 million per year	EQ
18/05	DocMorris : Governance presentation	PU
13/05	DocMorris : AGM voting results 2026	PU
12/05	2026 Annual General Meeting: Strong vote by shareholders in favour of continuity in leadership and strategy	EQ
16/04	DocMorris : AGM Invitation 2026	PU
16/04	DocMorris : Q1 2026 Trading Update Presentation	PU
16/04	DocMorris publishes invitation to the Annual General Meeting	EQ
16/04	DocMorris achieves strong revenue growth in Q1 2026 – on track for EBITDA break-even	EQ
14/04	DocMorris : enhances its leading AI-powered health platform by partnering with Hello Inside to address metabolic healthcare	PU
19/03	DocMorris and Google partner to advance one of Europe’s leading AI-powered digital health platform	EQ
19/03	DocMorris achieves 2025 targets – focus on profitability, growth and expansion of digital health platform	EQ
19/03	DocMorris : Annual Report 2025	PU
19/03	DocMorris : Annual Results Presentation 2025	PU
03/03	DocMorris AG announces changes to its Board of Directors	EQ
12/02	DocMorris and Infermedica simplify health: from symptoms to solutions with the AI health companion	PU
02/02	Early redemption of the 6.875% Convertible Bonds due 2026	EQ
26/01	DocMorris repurchases convertible bonds maturing in 2026 with a nominal value of around CHF 14.4 million	EQ
20/01	DocMorris achieves 11.1 per cent revenue growth in 2025 – strong fourth quarter	EQ
13/11	DocMorris announces the results of the tender offer for its Outstanding Convertible Bonds due 2026	EQ
06/11	DocMorris announces the start of the tender offer period for its Outstanding Convertible Bonds due 2026	EQ
22/10/25	DocMorris successfully completes the placement of CHF 49.6 million Convertible Bonds due 2028	EQ
21/10/25	DocMorris launches approx. CHF 45 million Convertible Bonds due 2028 to fund early buyback of Convertible Bonds 2026	EQ
16/10/25	DocMorris accelerates sequential Rx growth and increases non-Rx revenue	EQ
05/09/25	DocMorris : safe and certified online supply of medicines	PU